ArticleInflammatory bowel diseases2024

Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort.

Rahul S Dalal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.